Clinical trial
The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) Malignancies
NCT07770126 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) Malignancies
- Lead sponsor
- Universiteit Antwerpen
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 24, 2025
- Completion date
- March 31, 2028
- Enrollment
- 150 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
atrophic gastritis, dysplasia stomach, functional dyspepsia, gastric cancer (gc), gastritis, gastritis chronic, helicobacter infection, intestinal metaplasia of gastric mucosa, nhph prevalence